2021
DOI: 10.1016/j.cis.2021.102366
|View full text |Cite
|
Sign up to set email alerts
|

Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(32 citation statements)
references
References 166 publications
1
29
0
Order By: Relevance
“…Given the differences in the evolution of protein profiles as a function of protein concentration, we decided to investigate the composition of the protein corona to identify stealth and biosafe protein coatings for in vivo applications. 21 According to the literature, 19 we characterized protein corona at low (HP = 5%) and high (HP = 50%) protein concentrations, where the largest difference in physical-chemical properties of nanoparticle–protein complexes is typically found. However, as Figure 3 a shows, the size of PL-protein complexes at low HP was too large ( D H > 500 nm) to be compatible with drug delivery purposes.…”
Section: Resultsmentioning
confidence: 99%
“…Given the differences in the evolution of protein profiles as a function of protein concentration, we decided to investigate the composition of the protein corona to identify stealth and biosafe protein coatings for in vivo applications. 21 According to the literature, 19 we characterized protein corona at low (HP = 5%) and high (HP = 50%) protein concentrations, where the largest difference in physical-chemical properties of nanoparticle–protein complexes is typically found. However, as Figure 3 a shows, the size of PL-protein complexes at low HP was too large ( D H > 500 nm) to be compatible with drug delivery purposes.…”
Section: Resultsmentioning
confidence: 99%
“…[ 99 ] Nevertheless, the formation of a protein corona may be beneficial and can be used to alter the physiological behavior of drug NCs. [ 97 ] Thus, a variety of experimental methods including FCS have been employed to get insights into the protein corona formation. [ 100 ] In particular, FCS was applied to investigate protein–nanoparticle interactions under both model (e.g., protein solutions) and physiological (e.g., blood serum) conditions.…”
Section: Nanocarriers In Biological Fluidsmentioning
confidence: 99%
“…The field of nanomedicine has largely motivated the study of nanoparticle–protein interactions to improve nanoparticle function in applications including drug delivery, disease diagnostics, treatment, and prevention. Nanoparticle-based sensors have been used to detect metal ions, small molecules, and proteins including biomarkers for early cancer and kidney disease. As nanotechnologies become more widely used in biological settings, it is increasingly important to understand and predict nanoparticle function and fate in vivo ; despite the successes of some, many nanomaterials produce unsatisfactory results or off-target effects during clinical trials. This translation of nanomedicines from laboratory development to clinical practice is limited by our lack of control over interactions between the nanoparticle and its surrounding bioenvironment. , Although the intrinsic physicochemical characteristics of the nanoparticle determine in vitro functionality, the environment around the nanoparticle in the applied setting, such as blood plasma for intravenous delivery, will play a dominant role in determining the ultimate nanoparticle fate and function.…”
Section: Nanoparticle-based Sensors For Agricultural Innovations and ...mentioning
confidence: 99%